Sex-gender differences in drug abuse: a shift in the burden of proof? - PubMed (original) (raw)
Review
Sex-gender differences in drug abuse: a shift in the burden of proof?
Cora Lee Wetherington. Exp Clin Psychopharmacol. 2007 Oct.
Abstract
In the early years of NIDA-supported drug abuse research, much of the research on women was treatment related and conducted out of concern for their pregnancy status. Since then, drug abuse research on women has expanded to include females of all ages, including infants, children, and adolescents, both human and animal. This expansion has also extended to the study of male-female differences. In the early years of the expansion, National Institutes of Health study sections demanded a heavy burden of proof from drug abuse researchers who proposed to study male-female differences. The need for such research appeared not to have face validity. The tide has now changed with the growing body of literature attesting to its scientific and clinical validity. This change is often reflected in concerns expressed in study sections reviewing drug abuse grant applications that an applicant does not propose to analyze the data for sex-gender differences when in fact the literature suggests that such differences would be observed. Although the change has been slow, it suggests that the burden of proof is shifting from having to defend why sex-gender differences should be studied to having to defend why they should not.
(c) 2007 APA
Similar articles
- Women and addiction: the importance of gender issues in substance abuse research.
Tuchman E. Tuchman E. J Addict Dis. 2010 Apr;29(2):127-38. doi: 10.1080/10550881003684582. J Addict Dis. 2010. PMID: 20407972 - Biological basis of sex differences in drug abuse: preclinical and clinical studies.
Lynch WJ, Roth ME, Carroll ME. Lynch WJ, et al. Psychopharmacology (Berl). 2002 Nov;164(2):121-37. doi: 10.1007/s00213-002-1183-2. Epub 2002 Sep 5. Psychopharmacology (Berl). 2002. PMID: 12404074 Review. - Gender issues and the pharmacotherapy of substance abuse.
Heading CE. Heading CE. IDrugs. 2008 Jun;11(6):428-32. IDrugs. 2008. PMID: 18509784 Review. - Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
Yeom HS, Shepard DS. Yeom HS, et al. J Ment Health Policy Econ. 2007 Dec;10(4):207-19. J Ment Health Policy Econ. 2007. PMID: 18166831 - Framework for gender differences in human and animal toxicology.
Gochfeld M. Gochfeld M. Environ Res. 2007 May;104(1):4-21. doi: 10.1016/j.envres.2005.12.005. Epub 2006 Apr 17. Environ Res. 2007. PMID: 16616135 Review.
Cited by
- Heavy Lifetime Cannabis Use and Mortality by Sex.
Vallée A. Vallée A. JAMA Netw Open. 2024 Jun 3;7(6):e2415227. doi: 10.1001/jamanetworkopen.2024.15227. JAMA Netw Open. 2024. PMID: 38842807 Free PMC article. - Gender differences in illicit drug access, use and use disorder: Analysis of National Survey on Drug Use and Health data.
Ellis RA, Bailey AJ, Jordan C, Shapiro H, Greenfield SF, McHugh RK. Ellis RA, et al. J Psychiatr Res. 2024 Jul;175:118-122. doi: 10.1016/j.jpsychires.2024.05.017. Epub 2024 May 4. J Psychiatr Res. 2024. PMID: 38728914 - Association between cannabis use and blood pressure levels according to comorbidities and socioeconomic status.
Vallée A. Vallée A. Sci Rep. 2023 Feb 5;13(1):2069. doi: 10.1038/s41598-022-22841-6. Sci Rep. 2023. PMID: 36740601 Free PMC article. - Consideration of sex and gender differences in addiction medication response.
McKee SA, McRae-Clark AL. McKee SA, et al. Biol Sex Differ. 2022 Jun 27;13(1):34. doi: 10.1186/s13293-022-00441-3. Biol Sex Differ. 2022. PMID: 35761351 Free PMC article. Review. - Ethanol pre-exposure differentially impacts the rewarding and aversive effects of α-pyrrolidinopentiophenone (α-PVP): Implications for drug use and abuse.
Nelson KH, Manke HN, Bailey JM, Vlachos A, Maradiaga KJ, Huang S, Weiss TD, Rice KC, Riley AL. Nelson KH, et al. Pharmacol Biochem Behav. 2021 Dec;211:173286. doi: 10.1016/j.pbb.2021.173286. Epub 2021 Oct 8. Pharmacol Biochem Behav. 2021. PMID: 34634300 Free PMC article.